Evidence

The studies behind the line

We would rather you evaluate the evidence honestly than oversell it. Here is the headline research for each peptide, the strongest findings, and the gaps worth knowing about. Full reference lists live on each product page.

How to read this evidence

Most peptide bioregulator research is preclinical and mechanistic, with a smaller body of human work. That is the honest state of the field. We label what is clinical, what is practitioner protocol, and what is community-level so you can weigh it yourself. Where a body of evidence leans on a single research group or an unpublished trial, we say so.

BPC-157

  • Vasireddi N et al. 2025. Systematic review of BPC-157 in orthopaedic sports medicine. HSS Journal. 36 studies (35 preclinical, 1 clinical). DOI 10.1177/15563316251355551.
  • Sikiric P et al. 2020. Stable gastric pentadecapeptide BPC 157. Gut and Liver 14:153. PMID 31158953.
  • Chang CH et al. 2014. BPC 157 enhances growth-hormone receptor expression in tendon fibroblasts. PMC6271067.
  • Caveat worth sharing: roughly 80% of the BPC-157 literature comes from one group (Sikiric, Zagreb), and the Pliva Phase II ulcerative colitis trial was reported as safe and effective but never published in a peer-reviewed journal.

KPV

  • Dalmasso G et al. 2008. PepT1-mediated KPV uptake reduces intestinal inflammation. Gastroenterology 134:166. PMID 18061177.
  • Kannengiesser K et al. 2008. KPV in DSS and T-cell-transfer colitis. Inflamm Bowel Dis 14:324.
  • Xiao B et al. 2017. Orally targeted KPV nanoparticles alleviate ulcerative colitis. Mol Ther 25:1628. PMID 28143741.
  • Caveat: no published human RCT for oral KPV alone. Evidence is mechanistic plus animal models plus practitioner case series.

Epitalon

  • Khavinson research program on pineal peptides and telomerase activation, with a 2025 replication of the telomerase effect.
  • Effects on age-related melatonin decline and circadian restoration.
  • See the Epitalon product page for the full reference list and the honest framing on longevity claims.

TB4 Frag

  • Thymosin Beta-4 and the Ac-SDKP fragment: anti-fibrotic (TGF-beta/Smad) and macrophage-modulating mechanisms.
  • Caveat: no Phase 2/3 human trials for the Ac-SDKP fragment specifically. See the product page.

Thymogen Alpha 1

  • Khavinson identification of the Glu-Trp dipeptide as the active fragment of the thymic extract Thymalin.
  • Important distinction: Thymogen is not identical to injectable Thymosin Alpha-1 (Zadaxin). It is the orally available short version that carries part of that immune-modulating signal. See the product page.
Full references on each product pageEvery product page lists its complete study set with PMIDs and DOIs. For individualized clinical questions, contact Dr. Porter at integrativemedutah.com.